Literature DB >> 3415556

The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy.

H A Sen1, T J Robertson, B P Conway, P A Campochiaro.   

Abstract

Rabbits were given an intravitreous injection of 5.0 x 10(5) rabbit retinal pigment epithelial (RPE) cells, human RPE cells, or human dermal fibroblasts in one eye and an injection of vehicle alone in the other eye. Some rabbits were treated with retinal cryopexy or intravenous sodium iodate on the day before injection. Vitreous fluorophotometry (VFP) and fundus examinations were performed before and at various times after cell injections. Retinal detachments were graded by premortem ophthalmoscopic examinations and postmortem gross pathologic examinations. Eyes injected with cells had higher VFP readings than eyes injected with vehicle at all time points. Eyes injected with fibroblasts or rabbit RPE had significantly higher mean VFP values before the onset of retinal detachment than those injected with human RPE cells. Within each group, high levels of fluorescein leakage in the first week correlated well with severity of subsequent traction retinal detachment and the fibroblast and rabbit RPE groups had more severe detachments than the human RPE group. Treatment with cryopexy or sodium iodate resulted in higher VFP readings, a higher frequency of retinal detachments, and detachments that occurred earlier and that were more severe. These data demonstrate that intravitreous cells cause blood-retinal barrier breakdown in rabbits and that the amount and duration of this breakdown are important variables in retinal detachment formation.

Entities:  

Mesh:

Year:  1988        PMID: 3415556     DOI: 10.1001/archopht.1988.01060140451051

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  11 in total

Review 1.  The pars plana incision: experimental studies, pathologic observations, and clinical experience.

Authors:  A E Krieger
Journal:  Trans Am Ophthalmol Soc       Date:  1991

2.  Retinal pigment epithelial cell proliferation: potentiation by monocytes and serum.

Authors:  R Osusky; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

3.  Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy.

Authors:  P V Algvere; K Hallnäs; E Dafgård; A Höög
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

4.  Pars plana incisions of four patients: histopathology and electron microscopy.

Authors:  F H Koch; A E Kreiger; M Spitznas; B Glasgow; R Y Foos; M O Yoshizumi
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

5.  Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment.

Authors:  M S Seo; N Okamoto; M A Vinores; S A Vinores; S F Hackett; H Yamada; E Yamada; N L Derevjanik; W LaRochelle; D J Zack; P A Campochiaro
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

6.  Thrombin regulates chemokine induction during human retinal pigment epithelial cell/monocyte interaction.

Authors:  A Yoshida; S G Elner; Z M Bian; S L Kunkel; N W Lukacs; V M Elner
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

7.  Induction of interleukin-8 in human retinal pigment epithelial cells after denuding injury.

Authors:  A Yoshida; S G Elner; Z M Bian; V M Elner
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

Review 8.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

9.  A multivariate analysis of anatomic success of retinal detachments treated with scleral buckling.

Authors:  W S Grizzard; G F Hilton; M E Hammer; D Taren
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117

Review 10.  Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy.

Authors:  Hiroki Kaneko; Hiroko Terasaki
Journal:  Transl Vis Sci Technol       Date:  2017-07-10       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.